A podcast exploring the DaBlaCa-13 study, chemoresection with dose-dense mitomycin C (MMC) in patients with recurrent non-muscle-invasive bladder cancer (intermediate-risk)
Tune in for a fascinating discussion with Jørgen Bjerggaard Jensen, as he explores recent breakthroughs in non-muscle-invasive bladder cancer management through mitomycin C (MMC) chemoresection.